ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB
Nov 30, 2006
Citations
0
Citations
Journal
Evidence Based Medicine
Full text
Semantic Scholar
Key Takeaway Key Takeaway: Anti-TNF antibody therapy for rheumatoid arthritis increases the risk of serious infections and malignancies.
Abstract
THERAPEUTICS c Review: Anti-tumor necrosis factor antibody therapy for rheumatoid arthritis increases risk for serious infection and malignancy Bongartz T, Sutton AJ, Sweeting MJ, et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006;295:2275–85.
Text copied to clipboard
copied to clipboard